GLS and metastatic malignant neoplasm in the lymph nodes: They found a significantly decreased survival rate as well as an increased correlation with lymph node metastasis and advanced clinical stage in tumours where GLS1 had an increased expression when compared to tumours with a lower GLS1 level [90].